IL140982A0 - Coadministration of acat and mmp inhibitors for the treatment of atherosclerotic lesions - Google Patents
Coadministration of acat and mmp inhibitors for the treatment of atherosclerotic lesionsInfo
- Publication number
- IL140982A0 IL140982A0 IL14098299A IL14098299A IL140982A0 IL 140982 A0 IL140982 A0 IL 140982A0 IL 14098299 A IL14098299 A IL 14098299A IL 14098299 A IL14098299 A IL 14098299A IL 140982 A0 IL140982 A0 IL 140982A0
- Authority
- IL
- Israel
- Prior art keywords
- coadministration
- acat
- treatment
- atherosclerotic lesions
- mmp inhibitors
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Pyrane Compounds (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Pyridine Compounds (AREA)
- Indole Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Furan Compounds (AREA)
- Quinoline Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US9363998P | 1998-07-21 | 1998-07-21 | |
| PCT/US1999/013948 WO2000004892A2 (en) | 1998-07-21 | 1999-06-18 | Coadministration of acat and mmp inhibitors for the treatment of atherosclerotic lesions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL140982A0 true IL140982A0 (en) | 2002-02-10 |
Family
ID=22239992
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL14098299A IL140982A0 (en) | 1998-07-21 | 1999-06-18 | Coadministration of acat and mmp inhibitors for the treatment of atherosclerotic lesions |
Country Status (25)
| Country | Link |
|---|---|
| EP (1) | EP1098662A2 (xx) |
| JP (1) | JP2002521328A (xx) |
| KR (1) | KR20010083134A (xx) |
| CN (1) | CN1310629A (xx) |
| AP (1) | AP2001002035A0 (xx) |
| AU (1) | AU4701799A (xx) |
| BG (1) | BG105162A (xx) |
| BR (1) | BR9912296A (xx) |
| CA (1) | CA2335062A1 (xx) |
| CZ (1) | CZ2001126A3 (xx) |
| EA (1) | EA200100153A1 (xx) |
| EE (1) | EE200100046A (xx) |
| HR (1) | HRP20010055A2 (xx) |
| HU (1) | HUP0102880A3 (xx) |
| ID (1) | ID30030A (xx) |
| IL (1) | IL140982A0 (xx) |
| IS (1) | IS5809A (xx) |
| NO (1) | NO20010291D0 (xx) |
| OA (1) | OA11584A (xx) |
| PL (1) | PL346011A1 (xx) |
| SK (1) | SK502001A3 (xx) |
| TR (1) | TR200100205T2 (xx) |
| WO (1) | WO2000004892A2 (xx) |
| YU (1) | YU3501A (xx) |
| ZA (1) | ZA200100294B (xx) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2382676A1 (en) * | 1999-11-05 | 2001-05-17 | Warner-Lambert Company | Prevention of plaque rupture by acat inhibitors |
| GT200000203A (es) | 1999-12-01 | 2002-05-24 | Compuestos, composiciones y metodos para estimular el crecimiento y elongacion de neuronas. | |
| JP2003534239A (ja) * | 1999-12-17 | 2003-11-18 | ヴァージコア・インコーポレーテッド | 新規なスクシナート化合物、組成物、並びに使用及び調製方法 |
| AU8254101A (en) * | 2000-09-01 | 2002-03-22 | Sankyo Co | Medicinal compositions |
| GB0100761D0 (en) | 2001-01-11 | 2001-02-21 | Biocompatibles Ltd | Drug delivery from stents |
| JP4606027B2 (ja) * | 2002-04-03 | 2011-01-05 | トポターゲット ユーケー リミテッド | Ｈｄａｃ阻害剤としてのピペラジン結合を有するカルバミン酸化合物 |
| JP4617449B2 (ja) * | 2002-07-11 | 2011-01-26 | ヴィキュロン ファーマシューティカルズ インコーポレイテッド | 抗菌活性を有するｎ−ヒドロキシアミド誘導体 |
| WO2011092284A1 (en) * | 2010-01-29 | 2011-08-04 | Euroscreen S.A. | Novel amino acid derivatives and their use as gpr43 receptor modulators |
| CN104211695B (zh) * | 2013-06-04 | 2017-04-12 | 中国医学科学院医药生物技术研究所 | 一组胺甲酰基苯磺酰类化合物的用途 |
| EP3244883A1 (en) * | 2015-01-15 | 2017-11-22 | Biocant - Associação De Transferência De Tecnologia | Treatment of hutchinson-gilford progeria syndrome and diseases related to vascular ageing |
| CN106831697B (zh) * | 2017-03-15 | 2019-11-05 | 深圳市康道生物有限公司 | 川榛有效提取成分及其在防治动脉粥样硬化中的应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5366987A (en) * | 1991-08-22 | 1994-11-22 | Warner-Lambert Company | Isoxazolyl-substituted alkyl amide ACAT inhibitors |
| US5491172A (en) * | 1993-05-14 | 1996-02-13 | Warner-Lambert Company | N-acyl sulfamic acid esters (or thioesters), N-acyl sulfonamides, and N-sulfonyl carbamic acid esters (or thioesters) as hypercholesterolemic agents |
| PT841913E (pt) * | 1995-08-04 | 2003-06-30 | Warner Lambert Co | Utilizacao de derivados sulfamico acil sulfonamidas ou sulfonil carbamatos para a producao de um medicamento para reduzir os niveis de lipoproteinas |
| CA2253342A1 (en) * | 1996-05-17 | 1997-11-27 | Warner-Lambert Company | Biphenylsulfonamide matrix metalloproteinase inhibitors |
| KR20000068414A (ko) * | 1996-09-04 | 2000-11-25 | 로즈 암스트롱, 크리스틴 에이. 트러트웨인 | 매트릭스 메탈로프로테이나제 억제제 및 그의 치료적 용도 |
-
1999
- 1999-06-18 PL PL99346011A patent/PL346011A1/xx unknown
- 1999-06-18 WO PCT/US1999/013948 patent/WO2000004892A2/en not_active Application Discontinuation
- 1999-06-18 OA OA1200100022A patent/OA11584A/en unknown
- 1999-06-18 YU YU3501A patent/YU3501A/sh unknown
- 1999-06-18 CA CA002335062A patent/CA2335062A1/en not_active Abandoned
- 1999-06-18 HU HU0102880A patent/HUP0102880A3/hu unknown
- 1999-06-18 EP EP99930483A patent/EP1098662A2/en not_active Withdrawn
- 1999-06-18 AP APAP/P/2001/002035A patent/AP2001002035A0/en unknown
- 1999-06-18 AU AU47017/99A patent/AU4701799A/en not_active Abandoned
- 1999-06-18 EE EEP200100046A patent/EE200100046A/xx unknown
- 1999-06-18 ID IDW20010333A patent/ID30030A/id unknown
- 1999-06-18 CN CN99808958A patent/CN1310629A/zh active Pending
- 1999-06-18 JP JP2000560885A patent/JP2002521328A/ja active Pending
- 1999-06-18 CZ CZ2001126A patent/CZ2001126A3/cs unknown
- 1999-06-18 SK SK50-2001A patent/SK502001A3/sk unknown
- 1999-06-18 EA EA200100153A patent/EA200100153A1/ru unknown
- 1999-06-18 KR KR1020017000930A patent/KR20010083134A/ko not_active Application Discontinuation
- 1999-06-18 TR TR2001/00205T patent/TR200100205T2/xx unknown
- 1999-06-18 BR BR9912296-0A patent/BR9912296A/pt not_active IP Right Cessation
- 1999-06-18 IL IL14098299A patent/IL140982A0/xx unknown
-
2001
- 2001-01-10 ZA ZA200100294A patent/ZA200100294B/en unknown
- 2001-01-12 IS IS5809A patent/IS5809A/is unknown
- 2001-01-17 BG BG105162A patent/BG105162A/xx unknown
- 2001-01-18 NO NO20010291A patent/NO20010291D0/no not_active Application Discontinuation
- 2001-01-19 HR HR20010055A patent/HRP20010055A2/hr not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| BG105162A (en) | 2001-12-29 |
| EE200100046A (et) | 2002-06-17 |
| HUP0102880A3 (en) | 2002-11-28 |
| TR200100205T2 (tr) | 2001-05-21 |
| IS5809A (is) | 2001-01-12 |
| WO2000004892A3 (en) | 2000-05-18 |
| ID30030A (id) | 2001-11-01 |
| NO20010291L (no) | 2001-01-18 |
| CA2335062A1 (en) | 2000-02-03 |
| EA200100153A1 (ru) | 2001-08-27 |
| SK502001A3 (en) | 2002-06-04 |
| BR9912296A (pt) | 2001-04-17 |
| WO2000004892A2 (en) | 2000-02-03 |
| HUP0102880A2 (en) | 2002-06-29 |
| CN1310629A (zh) | 2001-08-29 |
| NO20010291D0 (no) | 2001-01-18 |
| YU3501A (sh) | 2005-06-10 |
| ZA200100294B (en) | 2002-01-10 |
| AU4701799A (en) | 2000-02-14 |
| OA11584A (en) | 2004-07-20 |
| HRP20010055A2 (en) | 2002-04-30 |
| JP2002521328A (ja) | 2002-07-16 |
| PL346011A1 (en) | 2002-01-14 |
| CZ2001126A3 (cs) | 2002-01-16 |
| EP1098662A2 (en) | 2001-05-16 |
| KR20010083134A (ko) | 2001-08-31 |
| AP2001002035A0 (en) | 2001-03-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB9800795D0 (en) | Prevention of multiple use of limited use devices | |
| EP1100392A4 (en) | METHODS AND DEVICES FOR REDUCING THE MINERAL CONTENT OF VASCULAR CALCIFIED LESIONS | |
| AU3034300A (en) | Substituted benzimidazoles and their use as parp inhibitors | |
| HUP0101613A3 (en) | Metalloprotease inhibitor (4-arylsulfonylamino)-tetrahydropyran-4-carboxylic acid hydroxamides and medicaments containing the same | |
| AU2212299A (en) | Compositions and methods for the treatment of tumor | |
| HK1094909A1 (en) | Use of il-18 inhibitors for the treatment and/or prevention of atherosclerosis il-18 | |
| HU0900792D0 (en) | Use of renin-angiotensin inhibitors | |
| HU9802971D0 (en) | The use of mmp inhibitors for the treatments of ocular angiogenesis | |
| AU3124300A (en) | Inhibitors of beta-lactamases and uses therefor | |
| GB2342045B (en) | Mineral and vitamin combinations for the treatment of stress and allergies | |
| AU2190400A (en) | Inhibitors of beta-lactamases and uses therefor | |
| HUP0102880A2 (en) | Coadministration of acat and mmp inhibitors for the treatment of atherosclerotic lesions | |
| HK1041827B (zh) | 用於治療雌激素依賴性疾病的化合物以及製備和使用上述化合物的方法 | |
| IT1302811B1 (it) | Procedimento e relativo apparato per la riduzione direttadi ossidi di ferro | |
| EP0964686A4 (en) | METHODS AND COMPOSITIONS FOR PREVENTING OR DELAYING THE DEVELOPMENT OF ATHEROSCLERIC LESIONS | |
| GB9816234D0 (en) | Compounds for use in the treatment of inflammation | |
| EP0983958A4 (en) | STAIRCASE AND STAIRCASE STEP | |
| HUP0101947A3 (en) | Combination for the treatment of tumors | |
| NO20004920D0 (no) | Anvendelse av proteaseinhibitorer for behandling av hudskader | |
| PL348029A1 (en) | Fluticasone lotion having improved vasoconstrictor activity | |
| AU7688998A (en) | Use of metalloproteinase inhibitors in the treatment and prevention of pulmonaryemphysema | |
| IL141056A0 (en) | Protease inhibitors for use in the treatment of psoriasis | |
| IT1302813B1 (it) | Dispositivo per la riduzione diretta di ossidi di ferroe relativo procedimento | |
| EP1135141A4 (en) | PHOSPHOLIPASE INHIBITORS FOR TREATING CANCER | |
| EP1086261A4 (en) | ANTI-CORROSION TREATMENT |